Ziopharm Oncology (ZIOP) Reports Q3 Loss of $0.14/Share
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q3 EPS of ($0.14), versus ($0.06) reported last year.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
- Provident Financial Services (PFS) Tops Q1 EPS by 3c
- Schlumberger (SLB) earnings in-line, revenue beats expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
